Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Angiodynamics (ANGO) Interest Expenses (2016 - 2024)

Angiodynamics (ANGO) has disclosed Interest Expenses for 15 consecutive years, with -$567000.0 as the latest value for Q2 2024.

  • For the quarter ending Q2 2024, Interest Expenses fell 162.93% year-over-year to -$567000.0, compared with a TTM value of -$567000.0 through Feb 2025, down 288.36%, and an annual FY2024 reading of -$1.6 million, down 159.73% over the prior year.
  • Interest Expenses was -$567000.0 for Q2 2024 at Angiodynamics, down from -$394000.0 in the prior quarter.
  • Across five years, Interest Expenses topped out at $901000.0 in Q2 2023 and bottomed at -$567000.0 in Q2 2024.
  • Average Interest Expenses over 5 years is $168777.8, with a median of $185000.0 recorded in 2021.
  • The sharpest move saw Interest Expenses soared 473.17% in 2020, then tumbled 178.07% in 2023.
  • Year by year, Interest Expenses stood at $235000.0 in 2020, then decreased by 25.96% to $174000.0 in 2021, then surged by 293.1% to $684000.0 in 2022, then crashed by 178.07% to -$534000.0 in 2023, then fell by 6.18% to -$567000.0 in 2024.
  • Business Quant data shows Interest Expenses for ANGO at -$567000.0 in Q2 2024, -$394000.0 in Q1 2024, and -$534000.0 in Q4 2023.